48 related articles for article (PubMed ID: 5802128)
1. [A search of new inhibitors of 5-hydroxytryptophane decarboxylase (5-HTP-D)].
Robak J
Folia Med Cracov; 1969; 11(1):125-55. PubMed ID: 5802128
[No Abstract] [Full Text] [Related]
2. [Pharmacology of several aromatic amino acid decarboxylase inhibitors].
Uspenskiĭ AE; Dabagov NS; Skoldinov AP
Biull Eksp Biol Med; 1978 Oct; 86(10):444-7. PubMed ID: 309344
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive agents 1962-1968.
Schier O; Marxer A
Prog Drug Res; 1969; 13():101-35. PubMed ID: 4391189
[No Abstract] [Full Text] [Related]
4. Some facts on drug--enzyme interactions and their relevance in discovery of new drugs.
Ahmad SI
J Pak Med Assoc; 1975 Jun; 25(6):136-9. PubMed ID: 814310
[No Abstract] [Full Text] [Related]
5. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
Maître L
J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
[No Abstract] [Full Text] [Related]
6. [Behavioral modifications observed following repeated administrations of monoamine oxidase inhibitors].
Goldwurm GF; Torrigiani G
Riv Neurobiol; 1964; 10(4):Suppl:1099-106. PubMed ID: 5827089
[No Abstract] [Full Text] [Related]
7. Mechanism of inhibition of beef liver mitochondrial monoamine oxidase by iproniazid.
Gomes B
Indian J Biochem Biophys; 1983 Apr; 20(2):96-9. PubMed ID: 6671669
[No Abstract] [Full Text] [Related]
8. [Action of different inhibitors of L-DOPA 5 HTP decarboxylase on insulin hypoglycemia in the rat].
CAHN J; HEROLD M; BARRE N
C R Seances Soc Biol Fil; 1963 Jul; 157():501-3. PubMed ID: 14017720
[No Abstract] [Full Text] [Related]
9. CLINICAL EXPERIENCE WITH THE MONOAMINE OXIDASE INHIBITOR, DL-SERINE-N-ISOPROPYLHYDRAZIDE (RO 4-1038), IN THE TREATMENT OF HYPERTENSION.
MAXWELL MH; ROTH SI; GONICK HC; KLEEMAN CR
Am Heart J; 1963 Aug; 66():151-63. PubMed ID: 14051181
[No Abstract] [Full Text] [Related]
10. [Effect of iproniazid on the tremor caused by some 2-substituted derivatives of tryptamine].
Ostrovskaia RU
Farmakol Toksikol; 1966; 29(6):668-72. PubMed ID: 6000363
[No Abstract] [Full Text] [Related]
11. [Apropos of the mechanism of action of monoamine oxidase-inhibitors on the coronary circulation].
Mirzoian RS
Farmakol Toksikol; 1965; 28(1):51-5. PubMed ID: 5845043
[No Abstract] [Full Text] [Related]
12. [Experimental animal research on the mechanism of the narcosis-shortening action of monoamine oxidase inhibitors].
WESTERMANN E; STOCK K
Chemotherapia (Basel); 1962; 4():329-39. PubMed ID: 14006333
[No Abstract] [Full Text] [Related]
13. The anti-monoamine oxidase effects of furazolidone.
Stern IJ; Hollifield RD; Wilk S; Buzard JA
J Pharmacol Exp Ther; 1967 Jun; 156(3):492-9. PubMed ID: 6028876
[No Abstract] [Full Text] [Related]
14. Phenylketonuria metabolites in cerebellum culture morphology.
Silberberg DH
Arch Neurol; 1967 Nov; 17(5):524-9. PubMed ID: 6069654
[No Abstract] [Full Text] [Related]
15. [Submicroscopic catecholamine stores as sites of attack of the psychopharmaca, reserpine and monoamine oxidase inhibitors].
Hassler R; Bak IJ
Nervenarzt; 1966 Nov; 37(11):493-8. PubMed ID: 5983176
[No Abstract] [Full Text] [Related]
16. [ACTION OF DOPA AND MONOAMINE OXIDASE INHIBITION BY IPRONIAZID ON THE BRAIN].
MONNIER M; GRABER S
Schweiz Arch Neurol Neurochir Psychiatr; 1963; 92():410-4. PubMed ID: 14059162
[No Abstract] [Full Text] [Related]
17. Possible involvement of ATP-dependent K-channel related mechanisms in the antihypertensive and cough suppressant effects of the novel ACE inhibitor (2S, 3aS, 7aS)-1-(N2-nicotinoyl-L-lysyl-gamma-D-glutamyl)octahydro-1H- indole-2-carboxylic acid.
Nagata S; Takeyama K; Hosoki K; Karasawa T
Arzneimittelforschung; 1997 Jun; 47(6):726-30. PubMed ID: 9239450
[TBL] [Abstract][Full Text] [Related]
18. [Iprazid and tersavid effects on the collateral circulation in dogs].
Solonenko EL
Farmakol Toksikol; 1966; 29(4):441-4. PubMed ID: 5987495
[No Abstract] [Full Text] [Related]
19. Novel indolyl pyrazolines as monoamine oxidase inhibitors.
Tripathi S; Pandey BR; Barthwal JP; Kishore K; Bhargava KP
Indian J Physiol Pharmacol; 1980; 24(2):155-9. PubMed ID: 7380531
[No Abstract] [Full Text] [Related]
20. New indolyl MAO inhibitors. Part 2.
Sathi G; Gujrati VR; Nath C; Bhargava KP; Shanker K
Pharmazie; 1982 Dec; 37(12):868-9. PubMed ID: 7163376
[No Abstract] [Full Text] [Related]
[Next] [New Search]
